Network

Investing in a Healthy Future

The VIC Investor Network features high-impact, high-return life science companies, with experienced done-it-before management teams, co-investment with experienced investors, and more.

Confidence

Angel investing with confidence

VIN addresses the primary challenges of angel investing in science and technology-driven innovation

Protection

Protection

Co-investment on same terms with larger investors and built-in investment safeguards

Diversification

Diversification

Investments may be made as low as $5k per invested company allowing more investments and portfolio diversification

Liquidity

Liquidity

Secondary market for VIN shares gives members opportunity for liquidity prior to portfolio exits

previous arrowprevious arrow
next arrownext arrow
ABOUT

The VIC Investor Network

Play Video
From breakthrough medical devices to lifesaving therapeutics, VIC companies develop commercially promising products and technologies that address important problems facing society and the world.
INNOVATION

VIC’s Innovation Ecosystem

Turnkey support through all stages of portfolio companies’ development.

Incubate high-potential ideas for future VIC portfolio companies.

Equity funding for proof-of-concept through commercial product roll-out.

Series A/B funding to reach major value-enhancing milestones.

PORTFOLIO

Our Portfolio Companies

Companies built from the ground up based on high impact technologies exclusively licensed from top research institutions around the world. View All Companies 

Now Funding
Zebra Analytix is focused on creating game-changing analytical solutions spanning diverse, high-impact applications where rapid detection is essential
Funded
Akeso Biomedical is an animal performance and food safety company developing new solutions to improve gut health and treat bacterial infections using a broad-spectrum chemistry.
Funded
ACQUIRED | Ascendant Dx is a bioscience company whose mission is to commercialize disruptive diagnostic technologies aiding identification and treatment for diseases of women and children.
Funded
BiologicsMD is developing highly targeted, novel human therapeutics for hair loss diseases and conditions, as well as severe bone disorders.
Funded
ACQUIRED | BlueInGreen (BIG) designs, manufactures and services the most efficient gas dissolution equipment for water and wastewater treatment.
Funded
Calyxo is developing a disruptive solution for kidney stone removal that is faster, easier, and better for patients, clinicians and hospitals.